CHICAGO (MarketWatch) -- Mylan Inc. said late Friday that it intends ... in litigation related to the anti-anxiety drugs Lorazepam and Clorazepate. The U.S. District Court for the District of ...

The 1998 lawsuit alleged Mylan of illegally inflating the price of its Lorazepam and Clorazepate drugs by as much as 3,200 percent, by cutting of the supply of the drugs' active ingredients to its ...

Then, according to the suits, Mylan raised the price of lorazepam from $7.30 for a bottle of 500 tablets to $190. The price for clorazepate rose from $11.36 to $377 for a bottle of 500.

In the lawsuits, the states and the FTC accused Mylan of entering into long-term, profit-sharing agreements with the companies that supply the active pharmaceutical ingredients for lorazepam and ...

In March 1998, Mylan raised the price of lorazepam 27-fold, increasing the cost of a 1,000-tablet supply of the drug from just under $14 to $378, government attorneys said. Lorazepam, a generic ...

New Delhi: Pfizer Ltd on Friday said its board has approved signing a marketing and supply agreement with Mylan Pharmaceuticals Pvt Ltd for two of its brands -- Ativan and Pacitane.